Brainstorm Cell Therapeutics (BCLI) had the best year in 2003 by a US stock in 2003, returning 4,605.9%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Brainstorm Cell Therapeutics (BCLI) | 2003 | 4,605.93% |
TherapeuticsMD (TXMD) | 2003 | 3,650% |
Millicom International Cellular (TIGO) | 2003 | 3,545.69% |
Live Ventures (LIVE) | 2003 | 2,769.99% |
Axon Enterprise (AXON) | 2003 | 1,933.84% |
8x8 Inc Common Stock (EGHT) | 2003 | 1,922.73% |
Dawson Geophysical (DWSN) | 2003 | 1,417.59% |
Encore Capital (ECPG) | 2003 | 1,272.73% |
Future Fintech (FTFT) | 2003 | 1,200% |
FARO Technologies (FARO) | 2003 | 1,194.3% |
Cal-Maine Foods (CALM) | 2003 | 942.98% |
Frontline (FRO) | 2003 | 856.86% |
Anika Therapeutics (ANIK) | 2003 | 836.54% |
Spok (SPOK) | 2003 | 829.67% |
Camtek (CAMT) | 2003 | 806.4% |
Cheniere Energy (LNG) | 2003 | 799.97% |
Ontrak (OTRK) | 2003 | 744.66% |
PEDEVCO (PED) | 2003 | 686.14% |
Neonode (NEON) | 2003 | 685.23% |
China Yuchai International (CYD) | 2003 | 679.05% |
Ribbon Communications (RBBN) | 2003 | 639.22% |
Empire Petroleum (EP) | 2003 | 639.11% |
Braskem SA Class A (BAK) | 2003 | 619.64% |
BioCryst Pharmaceuticals (BCRX) | 2003 | 585% |
Insmed (INSM) | 2003 | 575% |
